Biotech Stock Comparison

Compare the best Biotech stocks, get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.
Compare up to 10 stocks

Comparison Results

Name
Price
Price Change
Price Target Upside
Market Cap
PE Ratio
Yearly Gain
Analyst Consensus
Follow
GILDGilead Sciences
$69.47
-0.36 (-0.52%)
$79.57
(14.54% Upside)
$87.13B
16.60
2.89%
6Buy
3Hold
0Sell
Moderate Buy
AMGNAmgen
$235.45
-8.63 (-3.54%)
$227.45
(-3.40% Downside)
$135.28B
19.90
3.03%
6Buy
6Hold
1Sell
Moderate Buy
VRTXVertex Pharmaceuticals
$201.33
1.28 (0.64%)
$262.36
(30.31% Upside)
$52.23B
26.10
-27.44%
19Buy
5Hold
1Sell
Moderate Buy
BIIBBiogen
$339.00
1 (0.3%)
$433.38
(27.84% Upside)
$50.52B
26.10
22.43%
15Buy
13Hold
0Sell
Moderate Buy
ILMNIllumina
$501.98
3.56 (0.71%)
$442.50
(-11.85% Downside)
$73.29B
115.20
26.61%
3Buy
1Hold
1Sell
Moderate Buy

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Biotech Stocks Latest News

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Biotech Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
AMGNAmgen Inc
premium
premium
Buy
premium
premium
Reiterated
GILDGilead Sciences
premium
premium
Buy
premium
premium
Reiterated
BIIBBiogen Inc.
premium
premium
Hold
premium
premium
Reiterated
VRTXVertex Pharmaceuticals Inc.
premium
premium
Buy
premium
premium
Reiterated
ILMNIllumina
premium
premium
Buy
premium
premium
Reiterated
AMGNAmgen Inc
premium
premium
Hold
premium
premium
Reiterated
AMGNAmgen Inc
premium
premium
Hold
premium
premium
Assigned
VRTXVertex Pharmaceuticals Inc.
premium
premium
Hold
premium
premium
Reiterated
VRTXVertex Pharmaceuticals Inc.
premium
premium
Hold
premium
premium
Reiterated
VRTXVertex Pharmaceuticals Inc.
premium
premium
Buy
premium
premium
Reiterated

Most Recent Earnings of Biotech Stocks

SYMBOL
Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
GILDGilead Sciences
Jul 29, 2021
2021 (Q2)
1.74 / 1.21
-2.661
145.47% (+3.87)
AMGNAmgen
Aug 03, 2021
2021 (Q2)
4.09 / -
3.046
VRTXVertex Pharmaceuticals
Jul 29, 2021
2021 (Q2)
2.53 / 0.26
3.179
-91.95% (-2.92)
BIIBBiogen
Jul 22, 2021
2021 (Q2)
4.55 / 2.99
9.584
-68.82% (-6.60)
ILMNIllumina
Apr 27, 2021
2021 (Q1)
1.39 / 1.00
1.169
-14.46% (-0.17)

Biotech Stocks - FAQ

Which Biotech stocks have a "Strong Buy" analyst rating?
These Biotech stocks currently have a "Strong Buy" analyst rating consensus:
None of the selected stocks have a “Strong Buy” analyst rating consensus.
    Are Biotech stocks overpriced?
    Gilead Sciences's stock price is currently $69.47, and its average 12-month price target is $79.57.
      Amgen's stock price is currently $235.45, and its average 12-month price target is $227.45.
        Vertex Pharmaceuticals's stock price is currently $201.33, and its average 12-month price target is $262.36.
          Biogen's stock price is currently $339.00, and its average 12-month price target is $433.38.
            Illumina's stock price is currently $501.98, and its average 12-month price target is $442.50.
              Which Biotech stocks pay dividends?
              Gilead Sciences currently pays a dividend of $0.71 which represents an annual dividend yield of 4.02%. Gilead Sciences's next Ex-dividend date is September 14, 2021 and its next payout date is September 29, 2021.
                Amgen currently pays a dividend of $1.76 which represents an annual dividend yield of 2.71%. Amgen's next Ex-dividend date is August 16, 2021 and its next payout date is September 8, 2021.
                  Vertex Pharmaceuticals does not currently pay dividends.
                    Biogen does not currently pay dividends.
                      Illumina does not currently pay dividends.